Navigation Links
Aubrey Inc. Releases New Advanced Biosynthetic Wound Care Product 'AWBAT Plus'
Date:1/20/2011

CARLSBAD, Calif., Jan. 20, 2011 /PRNewswire/ -- Aubrey Inc. – http://www.aubreyinc.com – announced that after a successful soft release and product evaluation phase of its second generation product, AWBAT® Plus, it is now in full production and currently available for purchase.  Founder Aubrey Woodroof, PhD MBA, expresses his appreciation for being able to advance the art once again.  "It is a wonderful feeling to hear from a renowned surgeon that 'AWBAT® Plus has the potential to take wound coverage to the next level' and that it 'provides not only an optimal milieu but also a stimulus to promote active wound healing.'"

AWBAT® Plus utilizes the same patented technology for the precision-porous silicone-nylon membrane as the platform product, AWBAT®.  AWBAT® Plus, however, contains not only significantly more collagen but also chondroitin-4-sulfate, chondroitin-6-sulfate, vitamin C, vitamin E and Immuno-10 (activated mixture of polysaccharides from Aloe).  It was determined by FDA to be a combination product consisting of device components as well as drugs.  In subsequent laboratory testing, Immuno-10 was found to stimulate human dermal fibroblast proliferation, as well as fibroblast collagen and alpha-SMA production.  Human keratinocyte production was also enhanced by Immuno-10.  AWBAT® Plus is currently indicated for partial thickness burns, meshed autografts, and donor sites.

Woodroof stated: "We are very excited to have AWBAT® Plus now also available in our proprietary glove design.  Hand burns are common injuries and complex wounds to treat. The AWBAT® Plus Glove was designed specifically for ease of application and form fit, and to promote early mobility and rehabilitation, which is essential for maintaining functional dexterity and faster return to work."

Aubrey Inc. intends to seek clearance for use of AWBAT® Plus on chronic wounds this year.  Woodroof noted that in an investigator initiated evaluation of AWBAT® Plus on chronic wounds, the surgeon stated, "We have found AWBAT®-D Plus to be an effective alternative to Apligraf®, Dermagraft® and Integra® in preliminary observations of chronic wound management.  AWBAT®-D Plus can be used as an adjunct with NPWT."

About Aubrey Inc.

Dr. Aubrey Woodroof invented Biobrane® in 1978, an innovative product which revolutionized burn care.  In 2007, Woodroof came out of retirement to create the AWBAT® line as the next generation of advanced wound care technology.


'/>"/>
SOURCE Aubrey Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. CEL-SCI Corporation Releases Letter to Shareholders
3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Immunosyn Corporation Releases SF-1019 Study Results
6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
Breaking Medicine News(10 mins):